Abstract:Background and aim: Traumatic brain injury (TBI), a leading cause of high morbidity and mortality, represents a significant global public health challenge. Currently, no effective treatment for TBI exists. Curcumin, an active compound extracted from the root of Curcuma longa , has demonstrated neuroprotective properties both in vitro and in vivo . Notably, it has shown potential in reducing oxidative stress and inflammation and enhancing redox balance. This paper conducts a systematic review and meta-analysis to explore curcumin's role in TBI animal models extensively. The findings offer valuable insights for future human clinical trials evaluating curcumin as a therapeutic supplement or nutraceutical in TBI management. Methods: Comprehensive literature searches were conducted across MEDLINE, Embase, Cochrane, Web of Science, and Google Scholar databases. These searches aimed to identify relevant manuscripts in all languages, utilizing the keywords "curcumin" and "traumatic brain injury." Results: The final quantitative analysis included 18 eligible articles corresponding to animal studies. The analysis revealed that curcumin significantly reduced inflammatory cytokines, including IL-1β ( p = 0.000), IL-6 ( p = 0.002), and TNF-α ( p = 0.000), across various concentrations, time points, and administration routes. Additionally, curcumin markedly enhanced the activity of oxidative stress markers such as SOD ( p = 0.000), Sir2 ( p = 0.000), GPx ( p = 0.000), and Nrf2 ( p = 0.000), while reducing MDA ( p = 0.000), 4-HNE ( p = 0.001), and oxyprotein levels ( p = 0.024). Furthermore, curcumin improved cerebral edema ( p = 0.000) and upregulated neuroprotective factors like synapsin I ( p = 0.019), BDNF ( p = 0.000), and CREB ( p = 0.000), without reducing mNSS ( p = 0.144). About autophagy and apoptosis, curcumin increased the activity of Beclin-1 ( p = 0.000) and Bcl-2 ( p = 0.000), while decreasing caspase-3 ( p = 0.000), the apoptosis index ( p = 0.000), and P62 ( p = 0.002). Conclusion: Curcumin supplementation positively affects traumatic brain injury (TBI) by alleviating oxidative stress and inflammatory responses and promoting neuroprotection. It holds potential as a therapeutic agent for human TBI. However, this conclusion necessitates further substantiation through high-quality literature and additional randomized controlled trials (RCTs). Systematic Review Registration: https://www.crd.york.ac.uk/prospero/. The registration number of PROSPERO: CRD42023452685.

Curcumin Modulates TLR4/NF-κB Inflammatory Signaling Pathway Following Traumatic Spinal Cord Injury in Rats

Anti-inflammatory effects of curcumin in experimental spinal cord injury in rats

Curcumin Inhibits the Increase of Labile Zinc and the Expression of Inflammatory Cytokines after Traumatic Spinal Cord Injury in Rats.

Therapeutic Effect of Curcumin and Methylprednisolone in the Rat Spinal Cord Injury.

The role of thrombospondin-1 and transforming growth factor-β after spinal cord injury in the rat

Single-cell Sequencing Reveals the Optimal Time Window for Anti-Inflammatory Treatment in Spinal Cord Injury

Proteomics Reveals the Key Molecules Involved in Curcumin-induced Protection Against Sciatic Nerve Injury in Rats

Dl‐3‐n‐butylphthalide Attenuates Acute Inflammatory Activation in Rats with Spinal Cord Injury by Inhibiting Microglial TLR4/NF‐κB Signalling

Nano-formulated curcumin (Lipodisq™) modulates the local inflammatory response, reduces glial scar and preserves the white matter after spinal cord injury in rats

Curcumin/pEGCG-encapsulated nanoparticles enhance spinal cord injury recovery by regulating CD74 to alleviate oxidative stress and inflammation

Curcumin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE signaling pathway.

Administration with curcumin alleviates spinal cord ischemia-reperfusion injury by regulating anti-oxidative stress and microglia activation-mediated neuroinflammation via Nrf2/NF-κB axis

Curcumin Mitigates Neuro-Inflammation by Modulating Microglia Polarization Through Inhibiting TLR4 Axis Signaling Pathway Following Experimental Subarachnoid Hemorrhage

Neurological recovery and neurogenesis by curcumin sustained‐release system cross‐linked with an acellular spinal cord scaffold in rat spinal cord injury: Targeting NLRP3 inflammasome pathway

Curcumin in the treatment of inflammation and oxidative stress responses in traumatic brain injury: a systematic review and meta-analysis

Co-Delivery of Curcumin and Resveratrol via a Hydrogel/Nanoparticle System Modulate NF-kB Inflammatory Signalling Pathway in Rat Model of Traumatic Spinal Cord Injury

Curcumin alleviates neuroinflammation, enhances hippocampal neurogenesis, and improves spatial memory after traumatic brain injury

Curcumin and Curcuminoid Effects Modulating Chronic Mechanical Sensitivity in Spinal Nerve Ligation Model Revert Mitochondria Dysfunction and Oxidative Stress

Curculigoside Regulates Apoptosis and Oxidative Stress Against Spinal Cord Injury by Modulating the Nrf-2/NQO-1 Signaling Pathway In Vitro and In Vivo

Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress and nociceptive factors

Rutin Attenuates Neuroinflammation in Spinal Cord Injury Rats